Advertisement
Ascendis Pharma A/S

Ascendis Pharma A/S (ASND) Stock Overview

Explore Ascendis Pharma A/S’s financial performance, market position, analyst ratings, and future outlook.

ASND●NASDAQ
HealthcareBiotechnology
$218.84
$2.05(0.95%)
U.S. Market opens in 16h 8m
Advertisement

Ascendis Pharma A/S (ASND)

Meyka AI Score

Z

Key Financials

Market Cap13.5B
P/E Ratio22.75
EPS (TTM)$8.82
ROE-56.42%
Fundamental Analysis

AI Price Forecasts

1 Month$223.83
3 Months$259.48
1 Year Target$187.08

ASND Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascendis Pharma A/S (ASND) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $187.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.75 and a market capitalization of 13.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.95%
5-Day Change
-7.27%
1-Month Change
-4.32%
3-Month Change
-9.34%
6-Month Change
4.92%
Year-to-Date (YTD) Change
2.63%
1-Year Change
25.99%
3-Year Change
138.18%
5-Year Change
67.87%
All-Time (Max) Change
1062.19%

Contact Information

https://ascendispharma.com
45 70 22 22 44
Tuborg Boulevard 12, Hellerup, NaN, 2900

Company Facts

1,017 Employees
IPO DateJan 28, 2015
CountryDK
Actively Trading

Frequently Asked Questions